Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Directly Acting Antiviral Agents in Genotype 4 Hepatitis C Virus Relapse Among Egyptian Patients

NCT04662138 is registered in ClinicalTrials.gov with Alexandria University as lead sponsor.

NCT NCT04662138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04662138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Directly Acting Antiviral Agents in Genotype 4 Hepatitis C Virus Relapse Among Egyptian Patients
Lead sponsor
Alexandria University
Phase
Observational
Overall status
Unknown status
Start date
August 24, 2020
Completion date
May 28, 2022
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antivirals, hepatitis c, relapse